VANCOUVER, BC / ACCESSWIRE / November 7, 2025 / UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) (“UniDoc” or the “Company”) will attend and exhibit at the 42nd Annual ANCI Assembly in Bologna, Italy, from November 12–14, 2025.
ANCI is the national association of Italian municipalities. The annual assembly convenes mayors and municipal leaders from across Italy. UniDoc will be present at BolognaFiere with an exhibit at Booth #164–166.
Key Takeaways
- UniDoc exhibiting at ANCI 2025 in Bologna, November 12–14, Booth #164–166.
- Engagement aligned with Italy’s designation of the H3 Health Cube as preferred eHealth equipment.
- Meetings available on site; schedule via [email protected].
The 42nd Annual ANCI Assembly will take place at BolognaFiere in Bologna, Italy from November 12–14, 2025. The assembly draws municipal decision-makers and national institutions. In prior editions, it has included addresses from the President of the Republic and the Prime Minister, together with participation by central government ministries. Background information: https://www.anci.it/.
Attendance at ANCI follows Italy’s designation of the UniDoc H3 Health Cube as preferred equipment for eHealth initiatives. The designation led to initial orders and deployments in Italy, including the Municipality of Aliano.
“ANCI gathers the leaders who plan and fund local services,” said Tony Baldassarre, UniDoc’s Chief Executive Officer. “Our objective in Bologna is simple: meet with municipalities, demonstrate the H3 Health Cube, and align deployments with local care priorities across Italy.”
Parties wishing to schedule a meeting during the show can contact UniDoc at [email protected].
Exhibit Details
Dates: November 12–14, 2025 | Location: BolognaFiere, Bologna, Italy | Booth: #164–166
Marketing Engagement Update
Further to the Company’s news release of April 3, 2025, the Company is also pleased to announce it and Rumble Strip Media Inc. (“Rumble”) have agreed to extend the term of its previously marketing engagement(the “Original Engagement”) to provide certain social media, marketing, and consulting services to UniDoc (the “Services”) for an additional period of three months beginning on November 10, 2025 (the “Extended Term”). The Services may include investor relations activities within the meaning of applicable securities laws and the policies of the CSE. No additional consideration above the US $500,000 payable to Rumble as announced in the Company’s April 3, 2025 news release announcing the Original Engagement is payable to Rumble in connection with the renewed term. Due to market factors, the Company and Rumble paused the Original Engagement while there were still funds left in the marketing budget payable to Rumble and are now restarting the same Services in connection with the Extended Term until the remaining marketing budget is expended and the Extended Term expires. Rumble and its principal are arm’s length to the Company and, to the knowledge of the Company, Rumble does not own, control, or direct any securities of the Company. Rumble Strip Media Inc. (Address: #893 250-997 Seymour St, Vancouver, British Columbia, V6B 3M1; Email: [email protected]; Phone: 604-800-8824) is a Vancouver-based media and consulting firm.
On Behalf of the Board of Directors,
Antonio (Tony) Baldassarre
Chief Executive Officer, President & Director
About UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF)
UniDoc is developing an eHealth solution which is being designed as a self-contained remote virtual clinic within a private kiosk for patients to undergo full consultations as if they were present in a physician’s office. eHealth opens the doors to a large segment of the population challenged by access, experience or understanding of online computer technology. It is the Company’s belief that physical accessibility is the key to its business proposition. UniDoc is dedicated to unlocking shareholder value by delivering an excellent product and sophisticated commercial network within an expedited timeframe. The UniDoc team encourages engagement, questions, and interest, so please stay in touch and invite anyone who might be interested in our story to visit our website at https://unidoctor.com/ and signup to receive the latest information with updates on our activities, events and progress.
For further information, please contact:
UniDoc Investor Relations
Tel: +1 778.383.6731
Email: [email protected]
Matt Chatterton, Director
Tel: +1 778.613.2082
Email: [email protected]
Media Inquiries [email protected]
Forward-Looking Information
Certain information contained herein constitutes “forward-looking information” under Canadian securities legislation. Forward-looking information includes, but is not limited to: the use of proceeds of the Offering. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “anticipates”, “anticipated” “expected” “intends” “will” or variations of such words and phrases or statements that certain actions, events or results “will” occur. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made and they are from those expressed or implied by such forward-looking statements or forward-looking information subject to known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different, including receipt of all necessary regulatory approvals. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.
The CSE does not accept responsibility for the adequacy or accuracy of this release.